He announced his resignation in May
They found that while bleeding and infection occurred about as often whether or not the patients were taking GLP-1 drugs, hematoma and wound re-opening occurred markedly less often patients on GLP-1 drugs in the 180 days following surgery had just 71.1% the risk of wound reopening and 44.0% of the risk of hematoma, compared with patients who did not have GLP-1 drug prescriptions
This has been reflected in the medical literature
What is the recommended first-week dose of semaglutide GLP-1
[2] Levocarnitine injection carries no absolute contraindications in FDA labeling
A., Borum, P., Stall, C., Millspaugh, J., Taggart, E., and Lum, G